Abstract:Breast cancer is one of the most prevalent types of malignant tumor. Paclitaxel is widely used in the treatment of breast cancer; however, the major problem contributing to the failure of chemotherapy in breast cancer is the development of drug resistance. Therefore, it is necessary to identify novel therapeutic targets and reversal agents for breast cancer. In the present study, the protein expression levels of SET, protein phosphatase 2A (PP2A) and phosphatidylinositol 3-kinase (PI3K)/Akt pathway were determined in MCF-7/PTX human breast carcinoma paclitaxel-resistant cells using western blot analysis. Small interference RNAs (siRNAs) were used to knock down the gene expression of SET in MCF-7/PTX cells and the cell viability was assessed following treatment with paclitaxel, using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assays and flow cytometry. In addition, western blot analysis was used to determined PI3K/Akt pathway activity following SET knockdown. Furthermore, the reversal effects of paeonol on paclitaxel, and its underlying mechanisms of action, were investigated using western blot analysis and reverse transcription-quantitative polymerase chain reaction. The results demonstrated that increased levels of SET and PI3K/Akt pathway proteins were present in the MCF-7/PTX cells, compared with normal MCF-7 cells. Knockdown of SET significantly sensitized MCF-7/PTX cells to paclitaxel and induced cell apoptosis. In addition, the expression levels of the adenosine triphosphate binding cassette (ABC) transporter proteins were significantly reduced in the MCF-7/PTX cells compared with the normal MCF-7 cells. SET-induced paclitaxel resistance was found to be associated with the activation of the PI3K/Akt pathway. Paeonol significantly reduced the mRNA and protein expression levels of SET in the MCF-7/PTX cells. Furthermore, paeonol significantly sensitized the MCF-7/PTX to paclitaxel via regulation of ABC transporters, B cell lymphoma-2 (Bcl-2) and Bcl-2-associated X protein. In addition, paeonol inhibited SET-mediated paclitaxel resistance by attenuating PI3K/Akt pathway activity in the MCF-7/PTX cells. In conclusion, the results of the present study demonstrated that SET was associated with paclitaxel resistance in MCF-7/PTX cells, and that paeonol reversed paclitaxel resistance in MCF-7/PTX cells by downregulating the activity of the SET/PP2A/Akt pathway.

The role of Survivin in the apoptosis of MCF-7 cells induced by paclitaxel

Sensitization of Decitabine Combined with Paclitaxel on Proliferation Inhibition and Apoptosis Induction of Paclitaxel-resistant MCF-7 Cells

Targeted Inhibition of Notch1 Gene Enhances the Killing Effects of Paclitaxel on Triple Negative Breast Cancer Cells.

The Possible Correlation Between Activation of NF-kappaB/IkappaB Pathway and the Susceptibility of Tumor Cells to Paclitaxel-Induced Apoptosis.

Expression of Bcl-Xl and Survivin in Inhibition of Dexamethasone on Paclitaxel-induced Apoptosis in Human Ovarian Cancer Cell Line SKOV-3

Targeted Inhibition of Transient Activation of the EGFR-mediated Cell Survival Pathway Enhances Paclitaxel-Induced Ovarian Cancer Cell Death

Suppression of B7-H7 Enhanced MCF-7 Cancer Cell Line's Chemosensitivity to Paclitaxel

Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.

Inhibitory Effects of Paclitaxel on Human Embryonal Rhabdomyosarcoma Cell Line RD

Correlation Between Expression of Survivin or Its Change after Chemotherapy and the Effect of Paclitaxel in Breast Cancer

Mir-375 is Upregulated in Acquired Paclitaxel Resistance in Cervical Cancer

The antitumor effect of taxol and its regulation of survivin expression

Role of RAd-p53、E1B - -OLV and Paclitaxel on Breast Cancer Stem Cells

Effects of Paclitaxel on the Proliferative Activity and Surface Ultrastructure of Daudi Cells in Vitro

SB-T-121205, a Next-Generation Taxane, Enhances Apoptosis and Inhibits Migration/invasion in MCF-7/PTX Cells

Anti-cancer Mechanism of Survivin Sirna Plasmid Mu6/survivin

Mechanism of Taxol-Induced Apoptosis in Human Breast Cancer Cells

Effect and Mechanism of Survivin on Hypoxia-Induced Multidrug Resistance of Human Laryngeal Carcinoma Cells

Paclitaxel Induce Apoptosis of Giant Cells Tumor of Bone Via TP53INP1 Signaling

Tissue Inhibitor of Metalloproteinase‐1 Protects MCF‐7 Breast Cancer Cells from Paclitaxel‐induced Apoptosis by Decreasing the Stability of Cyclin B1

Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.